Charite Research Organisation GmbH; Phase - I Unit of Hematology and Oncology

Berlin 12200

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Systemic Lupus Erythematosus

Studies at this site

• Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy — Completed
• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Completed